Abstract
Asthma is one of the most prevalent chronic diseases worldwide, affecting approximately 10% of adults and an even greater proportion of children. Type-2 innate lymphoid cell (ILC2)-and type 2 helper T cell (T H 2)-driven type 2 inflammation is a critical contributor to the pathogenesis of this disease. Various triggers, such as protease allergens, helminth parasites, fungi and influenza virus, can stimulate epithelial cells to release alarmins such as IL-33, IL-25 and thymic stromal lymphopoietin (TSLP) to drive ILC2s and T H 2 activation. In this review, we provide some latest advances in our understanding of the role of ILC2s and T H 2 in asthma. With regard to T H 2, we focus on transcriptional factors, ubiquitination, Notch signaling pathway and clinical research. In the case of ILC2s, we concentrate on transcriptional factors, co-stimulatory molecules, epigenetic and metabolic pathways in a cell-intrinsic way and on cell-cell interaction in a cell-extrinsic way. The questions in this field are also addressed.
| Original language | English |
|---|---|
| Pages (from-to) | 115-128 |
| Number of pages | 14 |
| Journal | Current Trends in Immunology |
| Volume | 19 |
| State | Published - 2018 |
| Externally published | Yes |
Keywords
- Asthma
- ILC2
- T 2
- Therapeutic target
Fingerprint
Dive into the research topics of 'The regulatory function of T H 2 and ILC2 in asthma'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver